All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the Lymphoma Coalition.
ASCO Annual Meeting, 1-5 June 2018, Chicago, IL
Lombardi Comprehensive Cancer Center, Washington DC, US
Interview topic: Potential for chemotherapy-free future in lymphoid malignancies
Bruce Cheson | ASCO 2018 | Potential for chemotherapy-free future in lymphoid malignancies
New chemotherapy-free approaches for the treatment of lymphoid malignancies
At the 15th International Conference on Malignant Lymphoma, the Lymphoma Hub Satellite Symposium highlighted recent advances in chemotherapy-free options in the field of...
Management of patients with CLL after venetoclax discontinuation
Results from a study addressing the optimal treatment regimen after discontinuation of venetoclax and the impact of venetoclax resistance on the efficacy of subsequent therapies.
Subscribe to get the best content related to lymphoma & CLL delivered to your inbox